Management of juvenile hyperthyroidism.
D000293:Adolescent; D000380:Agranulocytosis / Q000139:chemically induced; D000469:Alkaline Phosphatase; D001862:Bone Resorption; D002118:Calcium / Q000378:metabolism; D003875:Drug Eruptions; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000150:complications / Q000628:therapy; D006980:Hyperthyroidism / Q000150:complications / Q000628:therapy*; D007456:Iodine Isotopes / Q000009:adverse effects / Q000627:therapeutic use*; D010758:Phosphorus / Q000378:metabolism; D011441:Propylthiouracil / Q000009:adverse effects / Q000627:therapeutic use*; D012709:Serum Albumin; D013963:Thyroid Hormones / Q000378:metabolism; D013965:Thyroidectomy; D013972:Thyrotropin / Q000378:metabolism; D014807:Vitamin D / Q000627:therapeutic use
D007456:Iodine Isotopes; D012709:Serum Albumin; D013963:Thyroid Hormones; D014807:Vitamin D; D010758:Phosphorus; D011441:Propylthiouracil; D013972:Thyrotropin; D000469:Alkaline Phosphatase; D002118:Calcium